KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Total Non-Current Liabilities (2016 - 2026)

Pfizer has reported Total Non-Current Liabilities over the past 18 years, most recently at $113.5 billion for Q1 2026.

  • Quarterly Total Non-Current Liabilities rose 1.65% to $113.5 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $113.5 billion through Mar 2026, up 1.65% year-over-year, with the annual reading at $5.7 billion for FY2025, 7.57% down from the prior year.
  • Total Non-Current Liabilities was $113.5 billion for Q1 2026 at Pfizer, up from $5.7 billion in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $121.0 billion in Q3 2024 and troughed at $5.7 billion in Q4 2025.
  • The 5-year median for Total Non-Current Liabilities is $102.0 billion (2025), against an average of $77.6 billion.
  • Year-over-year, Total Non-Current Liabilities surged 537.15% in 2023 and then fell 15.69% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $6.0 billion in 2022, then rose by 0.03% to $6.0 billion in 2023, then rose by 3.45% to $6.2 billion in 2024, then dropped by 7.57% to $5.7 billion in 2025, then soared by 1879.23% to $113.5 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Total Non-Current Liabilities are $113.5 billion (Q1 2026), $5.7 billion (Q4 2025), and $102.0 billion (Q3 2025).